对于乳腺癌管理的人工智能:概述
Harshita Gandhi1, Kapil Kumar1
1School of Pharmaceutical Sciences, Apeejay Stya University, Gurugram, Haryana 122103, India.
Current drug discovery technologies
|December 4, 2023
概括
人工智能 (AI) 和机器学习 (ML) 正在彻底改变乳腺癌护理. 这些技术提供了更好的早期检测,诊断和个性化治疗,提高了患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 生物医学信息学 生物医学信息学
- 计算生物学 计算生物学
背景情况:
- 乳腺癌对全球健康构成重大挑战.
- 早期检测,准确诊断和个性化治疗对于改善患者的治疗结果至关重要.
- 人工智能 (AI) 和机器学习 (ML) 在乳腺癌研究和临床实践中越来越重要.
研究的目的:
- 突出AI和ML在促进乳腺癌研究和临床应用中的新兴作用.
- 提供当前AI/ML项目在乳腺癌管理中的概述.
- 强调AI/ML在改变乳腺癌护理方面的潜力.
主要方法:
- 利用各种AI和ML算法,包括深度学习,卷积神经网络 (CNN),支持矢量机 (SVM) 和决策树.
- 分析各种数据集,如临床记录,基因组数据和医学成像.
- 开发用于诊断,预后和个性化治疗计划的预测模型.
主要成果:
- 人工智能和机器学习正在乳腺癌管理的多个方面应用,从早期检测到药物发现.
- 这些技术在提高诊断的准确性和个性化治疗的有效性方面具有潜力.
- 目前正在进行的项目在改善乳腺癌预后和患者治疗结果方面显示出有希望的结果.
结论:
- 人工智能和机器学习将有望显著改变乳腺癌护理.
- 对乳腺癌的AI/ML的持续研究和开发有望产生更准确和个性化的诊断和治疗策略.
- 整合AI/ML是改善患者乳腺癌管理结果的关键.
相关概念视频
Cancer Survival Analysis
356
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K


